curcumin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases glycated haemoglobin (HbA1c)
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Findingreplicated ×2“Compared with placebo, curcumin treatment significantly reduced FPG and HbA1c (key markers of diabetes progression) at 6, 9, and 12 months (Table 4; C).”
Quoted verbatim from Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.. - Study
- RCT
- Dose
- 1500 mg/day curcuminoid extract
- Population
- obese adults with type 2 diabetes mellitus, secondary endpoint, significant at 6, 9, 12 months
Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.2025PMID:41096556Industry fundedPermalink
Keep reading
- Everything the graph holds on curcumin
- Every compound studied against Glycated haemoglobin (HbA1c)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M3R2Z9MBPZ6XP4GRRQD3N651